Rationality Analysis of Antibiotics for Community-Acquired Pneumonia in Adult Inpatients at X Hospital Sukoharjo

Rolando Rahardjoputro, Adhi W. Amrullah, Wahyu Rizky, Ernawati Ernawati, Andrey Wahyudi, Nova R. Widyaningrum

Abstract


Community-acquired pneumonia in adult patients contributes to high morbidity and mortality rates. The rationality of antibiotics for community-acquired pneumonia pharmacotherapy can determine the result of patient clinical outcomes. The aim of this study was to determine antibiotics rationality for community-acquired pneumonia in adult inpatients at X Hospital Sukoharjo and relationship between antibiotics rationality and its clinical outcomes.This study was analytical cohort design with retrospective data in the form of patient medical records for the period 2022. Sampling method was carried out using total sampling with inclusion criteria being patients aged ≥ 18 years, male or female, diagnosed with community-acquired pneumonia and receiving antibiotic therapy. The total samples was 102 who met the inclusion criteria which 52% was female gender and predominantly aged ≥ 65. The rationality analysis using Gyssens method showed that 29.51% of antibiotics were given rationally with the highest number of irrationalities due to another more effective antibiotics (category IVA) at 54.90%. There was no significant relationship between antibiotic rationality and its clinical outcomes.

Keywords


rationality; antibiotic; community-acquired pneumonia; adult; inpatient

Full Text:

PDF

References


Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):E45–67.

Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet [Internet]. 2021;398(10303):906–19.

World Health Organization. Rational use of medicines: progress in implementing the WHO medicines strategy. World Health Organization. 2006.

Rumende CM, Chen LK, Karuniawat A, Bratanata J, Falasiva R, Sitorus TP, et al. Hubungan Antara Ketepatan Pemberian Antibiotik Berdasarkan Alur Gyssens dengan Perbaikan Klinis Pasien pada Pneumonia Komunitas. J Penyakit Dalam Indones. 2019;6(2):71.

Fatia UC, Supadmi W, Perwitasari DA, Yuniarti E. Hubungan Ketepatan Peresepan Antibiotik dengan Metode Gyssens dengan Perbaikan Klinis Pasien Rawat Inap Pneumonia Komunitas. J Ilmu Kefarmasian Indones. 2021;19(1):30–8.

Aljufri AQ, Yasin NM, Wahyono D. Rasionalitas Terapi Antibiotik Empiris Pada Pasien Pneumonia di Instalasi Rawat Inap RSUP Dr. Kariadi Semarang. Maj Farm. 2021;17(1):89.

Nisa RYC, Yulianti T. Evaluasi Penggunaan Antibiotik Pada Pasien Community-Acquired Pneumonia (CAP)Dengan Metode Gyssens Di Instalasi Rawat Inap RSUD Ir Soekarno Sukoharjo Tahun 2017. Univ Muhammadiyah Surakarta [Internet]. 2017;1–18.

Van Der Meer JWM, Gyssens IC. Quality of antimicrobial drug prescription in hospital. Clin Microbiol Infect. 2001;7(SUPPL. 6):12–5.

PDPI. Pneumonia Komuniti: Pedoman Diagnosis dan Penatalaksanaan di Indonesia. II. Jakarta: Perhimpunan Dokter Paru Indonesia (PDPI); 2014.

Ariyanti D, Sauriasari R, Yunir E. Evaluation of Current Practice of Antibiotic Use and Clinical Outcomes of Community-Acquired Pneumonia Patients with Type 2 Diabetes Mellitus at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Indones J Pharm. 2022;33(4):583–91.

Farida Y, Putri VW, Hanafi M, Herdianti NS. Profil Pasien dan Penggunaan Antibiotik pada Kasus Community-Acquired Pneumonia Rawat Inap di Rumah Sakit Akademik wilayah Sukoharjo. JPSCR J Pharm Sci Clin Res [Internet]. 2020 Oct 27;5(2):151.

Tim Riskesdas 2018. Laporan Riskesdas 2018 Nasional.pdf [Internet]. Lembaga Penerbit Balitbangkes. Jakarta: Lembaga Penerbit Balitbangkes; 2018.

Ravioli S, Gygli R, Funk G-C, Exadaktylos A, Lindner G. Prevalence and impact on outcome of sodium and potassium disorders in patients with community-acquired pneumonia: A retrospective analysis. Eur J Intern Med [Internet]. 2021;85:63–7.

Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, et al. Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia. 2015;75216(21):2199–208.

Lim WS, Baudouin S V, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64 Suppl 3:iii1-55.

Ministry of Health of the Republic of Indonesia. Peraturan Menteri Kesehatan Nomor 28 Tahun 2021 Tentang Pedoman Penggunaan Antibiotik [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2021.

Anggraini W, Lubis AS, Maimunah S, Hakim A. Evaluasi Kualitatif Penggunaan Antibiotik pada Pasien Pneumonia RS X di Malang. 2021;3(1):9–21.

Indonesian Doctors Association. Panduan Praktik Klinis : Bagi Dokter di Fasilitas Pelayanan Primer. 1st ed. Tim Editor PB IDI, editor. Jakarta: Ikatan Dokter Indonesia; 2017.

Spellberg B, Rice LB. Duration of Antibiotic Therapy : Shorter is Better. Ann Intern Med. 2020;171(3):210–1.

Suhartaty L, Pratiwi L, Purwanti NU. Evaluasi Penggunaan Antibiotik pada Pasien Pediatrik Rawat Inap di RSUD dr. Soedarso Pontianak. J Mhs Farm Fak Kedokt UNTAN. 2019;5(1).

Lacy CF, A LL, G MP. Drug Information Handbook: A Comprehensive Resource for All Clinicians and Healthcare Professionals [Internet]. 22nd ed. Lexi-Comp; 2013.




DOI: https://doi.org/10.15416/pcpr.v10i1.53198

Refbacks



                                                                         
Pharmacology and Clinical Pharmacy Research is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
 
                                                                      VIEW VISITOR STATS